mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0007 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0007 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
0.8 |
0.0009 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |